Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | TK2 | O00142 | 5/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Brivudine SCHEMBL13030272 | 1.00 | TK1 (1.00) | TK1CYP1A2CYP3A4TSHRBLM | |
| Brivudine SCHEMBL4283383 | 1.00 | TK1 (1.00) | TK1CYP1A2CYP3A4TSHRBLM | |
| Brivudine SCHEMBL4314668 | 1.00 | TK1 (1.00) | TK1CYP1A2CYP3A4TSHRBLM | |
| Brivudine SCHEMBL13674189 | 1.00 | TK1 (1.00) | TK1CYP1A2CYP3A4TSHRBLM | |
| Brivudine SCHEMBL1172398 | 1.00 | TK1 (1.00) | TK1CYP1A2CYP3A4TSHRBLM | |
| Brivudine SCHEMBL4283382 | 1.00 | TK1 (1.00) | TK1CYP1A2CYP3A4TSHRBLM | |
| Brivudine SCHEMBL99350 | 1.00 | TK1 (1.00) | TK1CYP1A2CYP3A4TSHRBLM | |
| Brivudine SCHEMBL5983819 | 1.00 | TK1 (1.00) | TK1CYP1A2CYP3A4TSHRBLM | |
| Brivudine SCHEMBL21316784 | 1.00 | TK1 (1.00) | TK1CYP1A2CYP3A4TSHRBLM | |
| Brivudine SCHEMBL15405329 | 1.00 | TK1 (1.00) | TK1CYP1A2CYP3A4TSHRBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 852 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4602052-A1 | PROTEIN-BASED SIGNAL AMPLIFICATION | California Institute of Technology (US) | 2025-08-20 | — | — | EP | claimed |
| US-12297241-B2 | Method to engineer transplantable human tissues | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-05-13 | — | — | US | claimed |
| EP-4388114-A1 | CELL-TO-CELL DELIVERY OF RNA CIRCUITS | California Institute of Technology (US) | 2024-06-26 | — | — | EP | claimed |
| EP-4370686-A1 | STOICHIOMETRIC EXPRESSION OF MESSENGER POLYCISTRONS | California Institute of Technology (US) | 2024-05-22 | — | — | EP | claimed |
| WO-2024081912-A1 | PROTEIN-BASED SIGNAL AMPLIFICATION | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2024-04-18 | — | — | WO | claimed |
| US-20240050580-A1 | COMPOSITIONS TARGETING TUMOR ASSOCIATED MACROPHAGES AND METHODS USING SAME | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-02-15 | — | — | US | claimed |
| EP-4305179-A2 | ACOUSTIC REMOTE CONTROL OF MICROBIAL IMMUNOTHERAPY | California Institute of Technology (US) | 2024-01-17 | — | — | EP | claimed |
| WO-2024011146-A1 | A SYNTHETIC PROTEIN-LEVEL NEURAL NETWORK IN MAMMALIAN CELLS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2024-01-11 | — | — | WO | claimed |
| WO-2023060047-A1 | THERMAL STATE SWITCHES IN MACROPHAGES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2023-04-13 | — | — | WO | claimed |
| US-20230103980-A1 | THERMAL STATE SWITCHES IN MACROPHAGES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2023-04-06 | — | — | US | claimed |
| WO-1996023506-A1 | USE OF 5'SUBSTITUTED NUCLEOSIDES TO PROVIDE RESISTANCE IN CYTOSTATIC TREATMENT AND MEDICAMENTS CONTAINING SAID NUCLEOSIDES | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 1996-08-08 | — | — | WO | claimed |
| WO-1994026273-A1 | ACYCLOVIR DERIVATIVES FOR TOPICAL USE | HOSTETLER KARL Y (US) | 1994-11-24 | — | — | WO | claimed |
| US-5159067-A | 5'-Diphosphohexose nucleoside pharmaceutical compositions | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC. (US) | 1992-10-27 | — | — | US | claimed |
| EP-0283065-B1 | COMBINATIONS OF FU AND BVU AS ANTI-ADENOCARCINOMA AGENTS | Stichting REGA V.Z.W. (BE) | 1991-05-29 | — | — | EP | claimed |
| US-4988678-A | Fluorouracil and tetrahydrofuryl-5-fluorouracil as an antitumor agent and bromovinyluracil and 5-(2-bromovinyl-2'-deoxyuridine | STICHTING REGA VZW (BE) | 1991-01-29 | — | — | US | claimed |
| US-4894365-A | 5-FLUOROURACIL AND BROMOVINYLURACIL | STICHTING REGA VZW (BE) | 1990-01-16 | — | — | US | claimed |
| EP-0143987-B1 | THERAPEUTIC COMPOSITIONS ENDOWED WITH ANTIVIRAL ACTIVITY | Stendardi, Anna Gioia (IT) | 1989-02-22 | — | — | EP | claimed |
| EP-0143987-A1 | Therapeutic compositions endowed with antiviral activity | Stendardi, Anna Gioia (IT) | 1985-06-12 | — | — | EP | claimed |
| EP-0090837-A1 | METHOD AND COMPOSITION FOR TREATING A PATIENT SUFFERING FROM INTERFERONSUSCEPTIBLE DISORDER | BERG, Kurt Frimann (DK) | 1983-10-12 | — | — | EP | claimed |
| WO-1983001198-A1 | METHOD AND COMPOSITION FOR TREATING A PATIENT SUFFERING FROM INTERFERON-SUSCEPTIBLE DISORDER | BERG, KURT, FRIMANN | 1983-04-14 | — | — | WO | claimed |